Naturally Occurring Cannabinoids and their Role in Modulation of Cardiovascular Health.

Journal of Dietary Supplements
Elnaz Karimian AzariAnnalouise O'Connor

Abstract

In recent years, the role of the endocannabinoid system (ECS) in various cardiovascular conditions has been a subject of great interest. The ECS is composed of cannabinoid receptors, their endogenous ligands, also known as endocannabinoids, and enzymes responsible for the synthesis and degradation of endocannabinoids. Several lines of evidence suggest that the ECS plays a complex role in cardiac and vascular systems; however, under normal physiological conditions the functions of the ECS are limited. Overactivation of components of the ECS has been associated with various cardiovascular conditions. Intriguingly, activation of the ECS may also reflect a cardioprotective compensatory mechanism. With this knowledge, a range of naturally occurring and synthetic cannabinoid receptor agonists and antagonists, as well as inhibitors of endocannabinoid metabolic enzymes have emerged as promising approaches for the treatment or management of cardiovascular health. This review will first focus on the known role of the ECS in regulating the cardiovascular system. Secondly, we discuss emerging data highlighting the therapeutic potential of naturally occurring non-psychoactive ECS modulators within the cardiovascular system, including phytoc...Continue Reading

References

Jan 1, 1975·Pharmacology·I G KarniolR E Musty
Nov 1, 1985·Proceedings of the Society for Experimental Biology and Medicine·G Nahas, R Trouve
Sep 1, 1973·British Journal of Pharmacology·J D Graham, D M Li
Nov 1, 1981·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·J A CornicelliB A Kottke
Nov 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·Z JáraiG Kunos
May 24, 2000·European Journal of Pharmacology·N E BuckleyA Zimmer
Oct 19, 2001·British Journal of Pharmacology·R WhiteC R Hiley
Mar 27, 2003·Journal of Cardiovascular Pharmacology·Andreas BonzJens Andreas Wagner
Jun 19, 2003·British Journal of Pharmacology·Philippe LépicierDaniel Lamontagne
May 4, 2004·The Journal of Physiology·Pál PacherGeorge Kunos
Sep 2, 2004·Nature Reviews. Drug Discovery·Vincenzo Di MarzoLuciano De Petrocellis
Jan 12, 2005·Diabetes, Obesity & Metabolism·B PoirierJ-M Herbert
Apr 12, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Pál PacherGeorge Kunos
Nov 18, 2005·The New England Journal of Medicine·Jean-Pierre DesprésUNKNOWN Rimonabant in Obesity-Lipids Study Group
Jan 31, 2006·Molecular and Cellular Biochemistry·Yelena A ShmistAsher Shainberg
Feb 16, 2006·JAMA : the Journal of the American Medical Association·F Xavier Pi-SunyerUNKNOWN RIO-North America Study Group
Mar 30, 2006·International Journal of Obesity : Journal of the International Association for the Study of Obesity·R G Pertwee
Sep 14, 2006·Pharmacological Reviews·Pál PacherGeorge Kunos
Mar 14, 2007·Current Opinion in Lipidology·Vincenzo Di Marzo, Stefania Petrosino
Mar 27, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Mohanraj RajeshPál Pacher
Apr 17, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Sándor BátkaiPál Pacher
Oct 30, 2007·British Journal of Pharmacology·N E Buckley
Apr 5, 2008·JAMA : the Journal of the American Medical Association·Steven E NissenUNKNOWN STRADIVARIUS Investigators
May 1, 2008·Nature Reviews. Drug Discovery·Vincenzo Di Marzo
Jun 25, 2008·Proceedings of the National Academy of Sciences of the United States of America·Jürg GertschAndreas Zimmer
Nov 11, 2008·Biochemical and Biophysical Research Communications·Mohanraj RajeshPál Pacher
Dec 9, 2008·Antioxidants & Redox Signaling·Milton HamblinY Eugene Chen
Jan 24, 2009·Journal of Molecular and Cellular Cardiology·Fabrizio MontecuccoSabine Steffens
Feb 28, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Nicole DeferCatherine Pavoine
Mar 12, 2009·Journal of Cardiovascular Pharmacology·C Robin Hiley

❮ Previous
Next ❯

Citations

Jul 28, 2020·Journal of Dietary Supplements·Igor Koturbash, Douglas MacKay

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Biological Psychiatry : Cognitive Neuroscience and Neuroimaging
Hui-Chen Lu, Ken Mackie
Annual Review of Nutrition
Mauro MaccarroneLuciana Avigliano
Journal of Ovarian Research
O'Llenecia S WalkerSandeep Raha
© 2021 Meta ULC. All rights reserved